Setting a traceability baseline
If your facility maintains detailed, auditable implant records by lot and serial identifier, apply the same baseline to any biologics vendor: full lot traceability from receipt to use, available on demand.
Test documentation turnaround before committing to a vendor, and confirm lot records would satisfy your facility's accreditation body, not only internal filing.
- Require lot-level traceability matching your existing documentation standards
- Test documentation turnaround before committing to a vendor
- Confirm lot records satisfy your facility's accreditation body
- Keep biologics traceability records in a consistent system with other regulated inventory
Budgeting order timing against case scheduling
If applicable to your practice, consider timing biologics orders against scheduled case volume rather than an insurance reimbursement cycle, and weigh storage costs against typical case booking lead time.
Track carrying cost for stock that sits unused between cases so order size reflects both case scheduling and storage capacity.
- Consider timing orders against scheduled case volume, if applicable
- Weigh storage costs against typical case booking lead time
- Track carrying cost for unused stock
- Revisit order size periodically as case volume shifts
Matching documentation to facility accreditation type
A private, office-based operating room and an accredited ambulatory surgical center may face different documentation expectations from their respective accrediting bodies. Confirm vendor paperwork fits whichever standard applies to your facility before the first order.
Resolving a documentation gap before an accreditation survey, rather than during one, avoids discovering it at the worst time.
- Confirm vendor documentation fits your facility's specific accreditation type
- Check documentation format against your accrediting body's requirements in advance
- Avoid assuming one documentation format fits every facility type
- Resolve documentation gaps before an accreditation survey, not during one
Regulatory review stays with counsel, not accreditation
Facility accreditation addresses surgical safety and operations. Whether a specific intended use meets all applicable criteria in 21 CFR 1271.10 is a separate determination for the practice's own regulatory counsel.
These products are not FDA approved or licensed for any disease or condition. Information here is for licensed healthcare professionals and is not medical or legal advice.
- Treat facility accreditation and HCT/P regulatory review as separate questions
- Confirm intended use classification with counsel, not the accrediting body
- Revisit the regulatory review if intended use or product format changes
- Keep records of both accreditation and regulatory review separately
Frequently asked questions
What traceability standard should a plastic surgery practice expect from a biologics vendor?+
The same lot-level traceability the facility already maintains for implants: a clear record from receipt through use, with documentation available on request.
Does a self-pay patient population change how a practice orders biologics?+
It can. If applicable to your practice, consider timing orders against your own case schedule rather than a reimbursement cycle, and weigh that against carrying cost on unused stock.
Does facility accreditation satisfy HCT/P regulatory requirements?+
No. Accreditation addresses surgical facility operations and safety. Whether a specific product and intended use meet 21 CFR 1271.10 is a separate determination for the practice's own regulatory counsel.